Effects of doxorubicin on maturation of human monocytes in adherent and non-adherent cultures. 1990

R C van Schie, and P H de Mulder, and H van Rennes, and H G Verstraten, and D J Wagener
Division of Medical Oncology, University Hospital Nijmegen, The Netherlands.

Purified human monocytes were cultured for 2 h, 88 h, and 10 days in plastic tubes (adherent) and for 10 days in Teflon foil bags (non-adherent). Monocytes were incubated with doxorubicin by two short-term exposures (750 or 1500 ng/ml) for 1 h or by continuous exposure (75 ng/ml). Maturation was monitored by measuring the intracellular activity of three metabolic enzymes and two acid hydrolases. Expression of receptors for the Fc moiety of immunoglobulin G (FcRI, FcRII, FcRIII), CD14, and HLA-DR was assayed by indirect immunofluorescence with monoclonal antibodies. In the presence of doxorubicin, the adherent capacity, the yield, and the enzyme activities reflecting growth and intermediary metabolism were similar to the control groups. However, doxorubicin reduced the expression of FcRI (32-45%), FcRII (10-26%), CD14 (20-37%), and HLA-DR (25-34%) on the monocyte-derived macrophages. Expression of FcRIII was not detectable after 10 days of culture.

UI MeSH Term Description Entries
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D011961 Receptors, Fc Molecules found on the surface of some, but not all, B-lymphocytes, T-lymphocytes, and macrophages, which recognize and combine with the Fc (crystallizable) portion of immunoglobulin molecules. Fc Receptors,Fc Receptor,Receptor, Fc
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D006684 HLA-DR Antigens A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS. HLA-DR,Antigens, HLA-DR,HLA DR Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015214 Antigens, Differentiation, Myelomonocytic Surface antigens expressed on myeloid cells of the granulocyte-monocyte-histiocyte series during differentiation. Analysis of their reactivity in normal and malignant myelomonocytic cells is useful in identifying and classifying human leukemias and lymphomas. Differentiation Antigens, Myelomonocytic,Myelomonocytic Differentiation Antigens,Antigens, Myelomonocytic, Differentiation,Antigens, Myelomonocytic Differentiation

Related Publications

R C van Schie, and P H de Mulder, and H van Rennes, and H G Verstraten, and D J Wagener
February 1996, Infection and immunity,
R C van Schie, and P H de Mulder, and H van Rennes, and H G Verstraten, and D J Wagener
August 1993, Journal of biomedical materials research,
R C van Schie, and P H de Mulder, and H van Rennes, and H G Verstraten, and D J Wagener
September 1986, Revista espanola de fisiologia,
R C van Schie, and P H de Mulder, and H van Rennes, and H G Verstraten, and D J Wagener
December 1992, Lymphokine and cytokine research,
R C van Schie, and P H de Mulder, and H van Rennes, and H G Verstraten, and D J Wagener
October 2022, Biology,
R C van Schie, and P H de Mulder, and H van Rennes, and H G Verstraten, and D J Wagener
October 2008, BMC cancer,
R C van Schie, and P H de Mulder, and H van Rennes, and H G Verstraten, and D J Wagener
August 2021, Biology,
R C van Schie, and P H de Mulder, and H van Rennes, and H G Verstraten, and D J Wagener
February 1991, Microgravity science and technology,
R C van Schie, and P H de Mulder, and H van Rennes, and H G Verstraten, and D J Wagener
March 1995, Journal of lipid mediators and cell signalling,
R C van Schie, and P H de Mulder, and H van Rennes, and H G Verstraten, and D J Wagener
January 1997, Haematologia,
Copied contents to your clipboard!